Codexis (NASDAQ: CDXS) reported Q4 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $26.56 million versus the consensus estimate of $19.9 million.

2024 Financial Guidance

Codexis is introducing financial guidance for 2024, as follows:

R&D revenues are expected to be in the range of $18 million to $22 million.
In addition, Codexis expects that its existing cash and cash equivalents will be sufficient to fund its planned operations through positive cash flow, expected around the end of 2026.

For earnings history and earnings-related data on Codexis (CDXS) click here.